2007
DOI: 10.1007/s00134-007-0955-x
|View full text |Cite
|
Sign up to set email alerts
|

The influence of corticosteroids on the release of novel biomarkers in human endotoxemia

Abstract: Objective: Sepsis intervention studies need better patient stratification methods, and one way to realize this is the introduction of stable biomarkers. A set of recently developed novel biomarkers, based upon precursor-fragments of short-lived hormones, was previously shown to be increased during sepsis. However, it is not known whether these biomarkers are influenced by sepsis intervention strategies. Therefore we investigated the markers in a model of human endotoxemia intervened by increasing doses of pred… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
58
0
4

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 98 publications
(68 citation statements)
references
References 20 publications
6
58
0
4
Order By: Relevance
“…29 An advantage of procalcitonin over other biomarkers is that its production is not significantly affected by nonsteroidal or steroidal anti-inflammatory drugs. [30][31][32] Our study has several limitations. The sample size was small and caution should be used when interpreting the results.…”
Section: Discussionmentioning
confidence: 99%
“…29 An advantage of procalcitonin over other biomarkers is that its production is not significantly affected by nonsteroidal or steroidal anti-inflammatory drugs. [30][31][32] Our study has several limitations. The sample size was small and caution should be used when interpreting the results.…”
Section: Discussionmentioning
confidence: 99%
“…34 One attractive aspect of PCT is that its level is not influenced by corticosteroid use. 35 In a study 36 with 102 critically ill patients with systemic bacterial infections receiving parenteral prednisolone 20-1500 mg/day, while appropriately high PCT levels were observed, significantly lower levels of CRP and IL-6 were observed. 36 …”
Section: Neutropenic And/or Immunosuppressed Patientsmentioning
confidence: 97%
“…Так, прием глюкокор-тикоидов существенно не влиял на уровень ПК. В то же время имеются данные о том, что при длитель-ном использовании высоких доз глюкокортикоидов О б з о р ы уровень ПК имеет тенденцию к снижению [38,[42][43][44][45][46]. Иммуносупрессоры и некоторые биологические пре-параты (ингибиторы фактора некроза опухоли α, ин-терлейкин 6, ритуксимаб) также не оказывали влияния на уровень ПКТ крови [43,47,48].…”
Section: болезнь стилла взрослыхunclassified